NATCO Pharma Limited, a pharmaceutical company based in Hyderabad, India, specializes in the development, manufacturing, and marketing of finished dosage formulations and active pharmaceutical ingredients (APIs). With a wide range of therapeutic areas covered, including cancers of blood, liver, kidney, lung, brain, breast, ovary, and more, the company offers formulations that cater to diverse medical needs. Their APIs are categorized into oncology, central nervous system, pain management, and CV care, ensuring a comprehensive approach to healthcare.
In addition to their pharmaceutical products, NATCO Pharma also provides orthopedic products like bisphosphonates, available in both oral and injectable forms, as well as gastroenterology products that consist of novel drugs for chronic hepatitis-B and hepatitis-C. The company also offers contract manufacturing services to meet the specific requirements of their clients.
Furthermore, NATCO Pharma offers cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF, addressing the needs of patients with cardiovascular conditions.
Expanding beyond the healthcare sector, the company also provides agro chemicals and biological pest management solutions for the effective management of insects, diseases, and weeds across various crops.
With a global presence, NATCO Pharma markets its products in approximately 50 countries, showcasing their commitment to making quality healthcare accessible worldwide. Since its incorporation in 1981, the company has been dedicated to advancing healthcare and improving the lives of individuals through its innovative products and services.
In addition to their pharmaceutical products, NATCO Pharma also provides orthopedic products like bisphosphonates, available in both oral and injectable forms, as well as gastroenterology products that consist of novel drugs for chronic hepatitis-B and hepatitis-C. The company also offers contract manufacturing services to meet the specific requirements of their clients.
Furthermore, NATCO Pharma offers cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF, addressing the needs of patients with cardiovascular conditions.
Expanding beyond the healthcare sector, the company also provides agro chemicals and biological pest management solutions for the effective management of insects, diseases, and weeds across various crops.
With a global presence, NATCO Pharma markets its products in approximately 50 countries, showcasing their commitment to making quality healthcare accessible worldwide. Since its incorporation in 1981, the company has been dedicated to advancing healthcare and improving the lives of individuals through its innovative products and services.
